Ayşe Kevser DEMİR, Göknur KALKAN, Havva Yıldız SEÇKİN, Zennure TAKCI, Yalçın ÖNDER, Şafak ŞAHİN, Rıza ÇITIL, Yalçın BAŞ

12151

Prevalence and related factors of psoriasis and seborrheic dermatitis: a community based study

Prevalence and related factors of psoriasis and seborrheic dermatitis: a community based study

Backgroud/aim: We aimed to determine the prevalence of psoriasis (PS) and seborrheic dermatitis (SD) (erythematous-squamous diseases) in our region and reveal the frequently encountered associated factors to aid in planning appropriate healthcare. Materials and methods: A community-based study was conducted with 85 sample groups that reflected the population rate and demography of Tokat Province in northern Anatolia. Results: In this community, the prevalence of PS in people older than 20 years of age was 1.2% and the prevalence of SD was 5.2%. SD rates were higher in patients who used tobacco and especially alcohol. SD prevalence was also higher in patients treated for depression and epilepsy. Furthermore, as education levels increased, SD prevalence increased proportionally. Conclusion: In general, PS prevalence in this region was higher than in Asia and Africa but lower than in Europe and the United States. Whereas SD prevalence varies between 2% and 12% throughout the world, the average SD prevalence was 5.2% in this study.
PDF

___

  • 1. Augustin M, Radtke MA. Quality of life in psoriasis patients. Expert Rev Pharmacoecon Outcomes Res 2014; 14: 559–568.
  • 2. Szepietowski JC, Reich A, Wesołowska-Szepietowska E, Baran E. Quality of life in patients suffering from seborrheic dermatitis: influence of age, gender and education level. Mycoses 2009; 52: 357–363.
  • 3. Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol 2014; 70: 512–516.
  • 4. Chang YT, Chen TJ, Liu PC, Chen YC, Chen YJ, Huang YL, Jih JS, Chen CC, Lee DD, Wang WJ et al. Epidemiological study of psoriasis in the national health insurance database in Taiwan. Acta Derm Venereol 2009; 89: 262–266.
  • 5. Ding X, Wang T, Shen Y, Wang X, Zhou C, Tian S, Liu Y, Peng G, Zhou J, Xue S et al. Prevalence of psoriasis in China: a population-based study in six cities. Eur J Dermatol 2012; 22: 663–667.
  • 6. Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005; 141: 1537–1541.
  • 7. de Avelar Breunig J, de Almeida HL, Duquia RP, Souza PRM, Staub HL. Scalp seborrheic dermatitis: prevalence and associated factors in male adolescents. Int J Dermatol 2012; 51: 46–49.
  • 8. Plunkett A, Merlin K, Gill D, Zuo Y, Jolley D, Marks R. The frequency of common nonmalignant skin conditions in adults in central Victoria, Australia. Int J Dermatol 1999; 38: 901–908.
  • 9. Nanda A, Al-Hasawi F, Alsaleh QA. A prospective survey of pediatric dermatology clinic patients in Kuwait: an analysis of 10,000 cases. Pediatr Dermatol 1999; 16: 6–11.
  • 10. Sterry W, Strober BE, Menter A. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol 2007; 157: 649–655.
  • 11. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55: 829– 835.
  • 12. Cohen AD, Dreiher J, Shapiro Y, Vidavsky L, Vardy DA, Davidovici B, Meyerovitch J. Psoriasis and diabetes: a population-based cross-sectional study. J Eur Acad Dermatol 2008; 22: 585–589.
  • 13. Gelfand JM, Dommasch ED, Shin DB, Azfar RS, Kurd SK, Wang X, Troxel AB. The risk of stroke in patients with psoriasis. J Invest Dermatol 2009; 129: 2411–2418.
  • 14. Yeung H, Takeshita J, Mehta NN, Kimmel SE, Ogdie A, Margolis DJ, Shin DB, Attor R, Troxel AB, Gelfand JM. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. J Am Acad Dermatol 2013; 149: 1173– 1179.
  • 15. Gupta AK, Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatol 2004; 18: 13–26.
  • 16. Maietta G, Fornaro P, Rongioletti F, Rebora A. Patients with mood depression have a high prevalence of seborrhoeic dermatitis. Acta Derm Venereol 1990; 70: 432–434.
  • 17. Armstrong AW, Schupp C, Wu J, Bebo B. Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003–2011. PLoS One 2012; 7: 1–6.
  • 18. Kimball AB, Robinson D Jr, Wu Y, Guzzo C, Yeilding N, Paramore C, Fraeman K, Bala M. Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001–2002. Dermatology 2008; 217: 27–37.
  • 19. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. J Amer Med Assoc 2006; 296: 1735–1741.
  • 20. Raychaudhuri SP, Farber EM. The prevalence of psoriasis in the world. J Eur Acad Dermatol 2001; 15: 16–17.
  • 21. Barker JNWN. Genetic aspects of psoriasis. Clin Exp Dermatol 2001; 26: 321–325.
  • 22. Henseler T. The genetics of psoriasis. J Am Acad Dermatol 1997; 37: 1–11.
  • 23. Schons KR, Knob CF, Murussi N, Beber AA, Neumaier W, Monticielo OA. Nail psoriasis: a review of the literature. An Bras Dermatol 2014; 89: 312–317.
  • 24. Bø K, Thoresen M, Dalgard F. Smokers report more psoriasis, but not atopic dermatitis or hand eczema: results from a Norwegian population survey among adults. Dermatology 2008; 216: 40–45.
  • 25. Wolkenstein P, Revuz J, Roujeau JC, Bonnelye G, Grob JJ, BastujiGarin S. Psoriasis in France and associated risk factors: results of a case-control study based on a large community survey. Dermatology 2009; 218: 103–109.
  • 26. Brandrup F, Green A. The prevalence of psoriasis in Denmark. Acta Derm Venereol 1981; 61: 344–346.
  • 27. Naldi L, Colombo P, Placchesi EB, Piccitto R, Chatenoud L, La Vecchia C. Study design and preliminary results from the pilot phase of the PraKtis study: self-reported diagnoses of selected skin diseases in a representative sample of the Italian population. Dermatology 2004; 208: 38–42.
  • 28. Seminara NM, Abuabara K, Shin DB, Langan SM, Kimmel SE, Margolis D, Troxel AB, Gelfand JM. Validity of the health improvement network (THIN) for the study of psoriasis. Br J Dermatol 2011; 164: 602–609.
  • 29. Barisić-Drusko V, Paljan D, Kansky A, Vujasinović S. Prevalence of psoriasis in Croatia. Acta Derm Venereol Suppl 1989; 146: 178–179.
  • 30. Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 2013; 133: 377–385.
  • 31. Doe PT, Asiedu A, Acheampong JW, Rowland Payne CM. Skin diseases in Ghana and the UK. Int J Dermatol 2001; 40: 323–326.
  • 32. Ogunbiyi AO, Daramola OO, Alese OO. Prevalence of skin diseases in Ibadan, Nigeria. Int J Dermatol 2004; 43: 31–36.
  • 33. Leder RO, Farber EM. The variable incidence of psoriasis in subSaharan Africa. Int J Dermatol 1997; 36: 911–919.
  • 34. Binder RL, Jonelis FJ. Seborrheic dermatitis in neurolepticinduced parkinsonism. Arch Dermatol 1983; 119: 473–475.
  • 35. Rocha N, Velho G, Horta M, Martins A, Massa A. Cutaneous manifestations of familial amyloidotic polyneuropathy. J Eur Acad Dermatol 2005; 19: 605–607.
  • 36. Sandyk R. Seborrhea and persistent tardive dyskinesia. Int J Neurosci 1990; 50: 223–236.
  • 37. Misery L, Touboul S, Vincot C, Dutray S, Rolland-Jacob G, Consoli SG, Farcet Y, Feton-Danou N, Cardinaud F, Callot V et al. Stress and seborrheic dermatitis. Ann Derm Venereol 2007; 134: 833–837.
  • 38. Cowley NC, Farr PM, Shuster S. The permissive effect of sebum in seborrhoeic dermatitis: an explanation of the rash in neurological disorders. Br J Dermatol 1990; 122: 71–76.
  • 39. Mastrolonardo M, Diaferio A, Logroscino G. Seborrhoeic dermatitis, increased sebum excretion, and Parkinson’s disease: a survey of [im]possible links. Med Hypotheses 2003; 60: 907–911.
  • 40. O’Neill CJ, Richardson MD, Charlett A, McHugh L, Bowes SG, Purkiss AG, Weller C, Dobbs SM, Dobbs RJ. Could seborrhoeic dermatitis be implicated in the pathogenesis of parkinsonism? Acta Neurol Scand 1994; 89: 252–257.
  • 41. Johnson BA, Nunley JA. Treatment of seborrheic dermatitis. Am Fam Physician 2000; 61: 2703–2710.
  • 42. Peyrí J, Lleonart M, the Spanish Group of the SEBDERM Study. Clinical and therapeutic profile and quality of life of patients with seborrheic dermatitis. Actas Dermosifiliogr 2007; 98: 476–482.
  • 43. Rosset M, Oki G. Skin diseases in alcoholics. Q J Stud Alcohol 1971; 32: 1017–1024.
  • 44. Barba A, Piubello W, Vantini I, Caliari S, Cocchetto R, Vallaperta P, Scuro LA, Sapuppo A, Cavallini G. Skin lesions in chronic alcoholic pancreatitis. Dermatologica 1982; 164: 322–326.
  • 45. Sudan BJL. Seborrheic dermatitis induced by nicotine of horsetails (Equisetum arvense L.). Contact Dermatitis 1985; 13: 201–202.
  • 46. Sudan BL, Brouillard C, Sterboul J, Sainte-Laudy J. Nicotine as a hapten in seborrheic dermatitis. Contact Dermatitis 1984; 11: 196–197.
  • 47. Ruiz Pérez L, Zapico Alvarez-Cascos M, Zubiaur Cantalapiedra A, Alfayate Guerra R, Sánchez-Paya J, Flores Serrano J. Lipid profile and hormonal study in the schoolchildren of the province of Alicante. Endocrinol Nutr 2009; 56: 158–163.
  • 48. García Hidalgo L. Dermatological complications of obesity. Am J Clin Dermatol 2002; 3: 497–506.
  • 49. Schwartz RA, Janusz CA, Janniger CK. Seborrheic dermatitis: an overview. Am Fam Phys 2006; 74: 125–130.
  • 50. Kligman AM. Perspectives and problems in cutaneous gerontology. J Invest Dermatol 1979; 73: 39–46.
  • 51. Lynch PJ. Dermatologic problems of the head and neck in the aged. Otolaryng Clin N Am 1982; 15: 271–285.
  • 52. Sardana K, Mahajan S, Sarkar R, Mendiratta V, Bhushan P, Koranne RV, Garg VK. The spectrum of skin disease among Indian children. Pediatr Dermatol 2009; 26: 6–13.
  • 53. Goh CL, Akarapanth R. Epidemiology of skin disease among children in a referral skin clinic in Singapore. Pediatr Dermatol 1994; 11: 125–128.
  • 54. Palamaras I, Kyriakis KP, Stavrianeas NG. Seborrheic dermatitis: lifetime detection rates. J Eur Acad Dermatol 2012; 26: 524–526.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Arşiv
Sayıdaki Diğer Makaleler

Yeşim ALTAY, Özgür BALTA

Review of 306 evisceration surgeries performed between 2005 and 2013

Fatma AKBAŞ KOCAOĞLU, Özgür BALTA, Firdevs ÖRNEK, Uğur ACAR

Amniotic membrane transplantation in bacterial and herpetic stromal keratitis

Yeşim ALTAY, Özgür BALTA, Sema TAMER, Ayşe BURCU

Efficacy of pegylated liposomal etoposide nanoparticles on breast cancer cell lines

Azim AKBARZADEH, Mohammadreza MEHRABI, Parisa ESMAEILPOUR, Zahra SAFFARI, Maryam FARAHNAK, Ali FARHANGI, Mohsen CHIANI

Sümeyye KAZANCIOĞLU, Esragül AKINCI, Aliye BAŞTUĞ, Bircan KAYAASLAN, Ayşe BUT, Halide ASLANER, Selim Sirri EREN, Meltem Arzu YETKİN, Hurrem BODUR

Genetic association of the COL1A1 gene promoter ?1997 G/T (rs1107946) andSp1 +1245 G/T (rs1800012) polymorphisms and keloid scars in a Jeddah population

Sabah A. LINJAWI, Sanaa E. TORK, Risa M. SHABIAH

The role of FDG PET/CT in detection of distant metastasis in theinitial staging of breast cancer

Muhammet Sait SAĞER, Kerim SÖNMEZOĞLU, Metin HALA, Pınar Çiğdem KOCAEL, Meftune ÖZHAN, Özgül EKMEKÇİOĞLU, Sabire YILMAZ AKSOY, Anar ALIYEV, Betül VATANKULU, Melih Engin ERKAN

Chenna ZHENG, Huiyong YANG, Qingyao WANG, Huachun RAO, Yong DIAO

The prevalence of tularemia in occupational groups that have contact with animals

Mehmet DOĞANAY, Özgür ÇELEBİ, Aliye GÜLMEZ SAĞLAM, Salih OTLU, Doğan AKÇA, Selçuk KILIÇ, Elif ÇELİK, Mitat ŞAHİN, Bekir ÇELEBİ, Fatih BÜYÜK

Retinopathy of prematurity: incidence, risk factors, and evaluation of screening criteria

Hamza YAZGAN, Haşim USLU, Bülent GÜRLER, Mehmet DEMİRDÖVEN, Alparslan TONBUL, Esengül KELEŞ, Bülent BAŞTÜRK, Aydın YILDIRIM, * Arzu GEBEŞÇE1